Perfil
Yoni Livne is currently the Chief Financial Officer at Bonus Biogroup Ltd. He previously worked as the Chief Financial Officer at Real Imaging Holdings Ltd. and as the Chief Controller at Dexcel Pharma Technologies Ltd. Livne received an undergraduate degree and an MBA from The Hebrew University of Jerusalem.
Cargos activos de Yoni Livne
| Empresas | Cargo | Inicio |
|---|---|---|
| BONUS BIOGROUP LTD. | Director Financiero/CFO | 01/06/2014 |
Antiguos cargos conocidos de Yoni Livne.
| Empresas | Cargo | Fin |
|---|---|---|
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes generic pharmaceuticals products | Comptroller/Controller/Auditor | - |
Real Imaging Holdings Ltd.
Real Imaging Holdings Ltd. Medical SpecialtiesHealth Technology Develops imaging and cancer detection devices for the treatment of breast cancer | Director Financiero/CFO | - |
Formación de Yoni Livne.
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
| Empresas privadas | 4 |
|---|---|
Bonus Biogroup Ltd.
Bonus Biogroup Ltd. Medical SpecialtiesHealth Technology Operates as a biotechnology company which develops regeneration therapies and biotechnology products for bones | Health Technology |
The Hebrew University of Jerusalem
The Hebrew University of Jerusalem Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Real Imaging Holdings Ltd.
Real Imaging Holdings Ltd. Medical SpecialtiesHealth Technology Develops imaging and cancer detection devices for the treatment of breast cancer | Health Technology |
Dexcel Pharma Technologies Ltd.
Dexcel Pharma Technologies Ltd. Pharmaceuticals: MajorHealth Technology Develops, manufactures and commercializes generic pharmaceuticals products | Health Technology |
- Bolsa de valores
- Insiders
- Yoni Livne
















